Across TCGA patient cohorts, RPL7P17 RNA expression is significantly associated with the RNA expression of many other genes, with 16,478 significant associations in total. DLBC shows the largest number of these associations.

The most reproducible RPL7P17-associated genes across cancer lineages are ZNRD1ASP, GLUD1P3, and NFYC-AS1. Each is linked with RPL7P17 in more than 31 cancer types. Because this analysis shows association rather than direction, both RPL7P17-to-partner and partner-to-RPL7P17 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (RPL7P17→partner) and Y-score (partner→RPL7P17) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LAML	ZNRD1ASP →	+0.535	+0.444	<.001	<.001	3	32
UCS	GLUD1P3 →	+0.801	+0.276	<.001	.004	2	32
DLBC	NFYC-AS1 →	+1.005	+0.170	<.001	.002	3	31
KIRP	GARS1-DT →	+0.785	+0.175	<.001	<.001	3	31
UVM	ZRANB2 →	+1.231	+0.139	<.001	.001	3	31
UCS	ANKRD36 →	+0.646	+0.261	<.001	.007	3	31

Each partner links to its Q-omics profile. Showing the 6 strongest of 16,478 associations by consensus.

Exploration

RPL7P17 survival (RNA) · tumor vs normal (RNA) · all RPL7P17 data types